EUROAPI was originally created and spun off by the major French multinational pharmaceutical corporation Sanofi to specialize in active pharmaceutical ingredient production. While Sanofi initially retained a significant equity stake following its stock market flotation on Euronext Paris, ownership distribution has evolved through institutional share placements, public market trading, and diverse equity investments from global asset managers.